We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

SemBioSys Completes pre-IND Meeting with U.S. FDA for APO AIMilano

News   Aug 12, 2009

 
SemBioSys Completes pre-IND Meeting with U.S. FDA for APO AIMilano
 
 
 

RELATED ARTICLES

Even Short-term Vaping Causes Inflammation in Non-smokers, Says Pilot Study

News

Researchers report the first evidence of biological changes correlated with e-cigarette use in never-smokers.

READ MORE

Fungus Chemistry May Mimic Opioids With Fewer Side Effects

News

The hunt for an opioid alternative has made a leap forward – a unique fungus may be able to mimic opioid suggesting it could be a safer less addictive drug, helping address the opioid epidemic of deaths by overdose.

READ MORE

Novel Strategy for Synthesizing Complex Natural Products

News

Scientists have succeeded in synthesizing two complex products from a group which could be used in the development of new drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE